Genome-Wide Significant SNPs from the Sex-Combined Multi-Ethnic Meta-Analysis.

<p>The novel loci identified using Multi-Ethnic Meta-analysis (that were not identified in the European only analysis) are listed in <b>bold</b>.</p>*<p>When possible, plausible biological candidate genes have been listed; otherwise, the closest gene is designated.</p>‡<p>Lead SNP is the SNP with the lowest <i>p</i>-value for each locus.</p>†<p>Positions are relative to Human Genome NCBI Build 36.</p>§<p>log₁₀ Bayes factor (BF) from the MANTRA analysis. A log₁₀ BF of 6 and higher was considered as a conservative threshold for genome-wide significance.</p>††<p>The posterior probability of heterogeneity between studies.</p>¶<p>EA: effect allele, NEA: non-effect allele.</p>¶¶<p>EAF: Frequency of effect allele in CEU, East Asian, and AA, populations respectively.</p

The Association of Lead Genome-Wide Significant SNPs for Adiponectin with mRNA Levels of Their Nearest Gene.

‡<p>Lead SNP is the SNP with the lowest <i>p</i>-value for each gene in gene expression data.</p>‡‡<p>Lead SNP is the SNP with the lowest <i>p</i>-value for each locus in meta-analysis from discovery phase.</p>¶<p>EA: Effect allele.</p>¶¶<p>EAF: Frequency of effect allele.</p>§<p>Betas are estimated expression levels of the genes.</p>*<p>P value for lead SNP is the SNP in gene expression data.</p>**<p>P value for lead SNP in meta-analysis from discovery phase.</p>$<p>r² LD between lead SNP from expression and lead SNP from meta-analysis.</p

Flow chart of study design.

<p>Flow chart of study design.</p

The Association of mRNA Levels from Genes in Candidate Loci in Human Adipocytes with Circulating Adiponectin Levels.

§<p>Betas are estimated from log transformed and quantile-quantile normalized values.</p>*<p>These two loci are independent loci.</p

Regional plots of eight newly discovered genome-wide significant chromosomal regions associated with adiponectin concentrations in European populations.

<p>A) chromosome 16q23.2, B) chromosome 19 q13.11 C) Chromosome 3p21.1, D) two loci on chromosome 12q24.31, E) chromosome 8q24.13, F) chromosome 6p21.1, and G) chromosome 1q41. In each panel, purple diamonds indicate the top SNPs, which have the strongest evidence of association. Each circle shows a SNP with a color scale relating the r² value for that SNP and the top SNP from HapMap CEU. Blue lines indicate estimated recombination rates from HapMap. The bottom panels illustrate the relative position of genes near each locus. Candidate genes are indicated by red ovals.</p

Lead SNP per Locus for Genome-Wide Significant SNPs Arising from the Sex-Combined Meta-Analysis in European Populations.

<p> <i>All SNPs achieving genome-wide significance in the joint analysis phase are marked in italics.</i></p>*<p>Joint analysis indicates results from the meta-analysis of discovery and follow-up <i>in-silico</i> and <i>de-novo</i> phases.</p>**<p>When possible, plausible biological candidate genes have been listed; otherwise, the closest gene is designated.</p>‡<p>Lead SNP is the SNP with the lowest <i>p</i>-value for each locus.</p>§<p>Betas are estimated from models using the natural log transformed adiponectin.</p>¶<p>EA: Effect allele, NEA: Non-effect allele.</p>¶¶<p>EAF: Effect allele frequency.</p

Manhattan plots for meta-analyses in the discovery phase.

<p>A) Combined sex analysis in European populations, B) Meta-Analysis of Multiple Ethnicities. The Manhattan plots show −Log₁₀ (<i>p</i>-value) measures for association between single nucleotide polymorphisms (SNPs) and chromosomal position. The SNPs that achieved genome-wide significance are highlighted in green.</p